Injury to the vertebrate brain causes neuroinflammation, characterized in part by increases in prostaglandins. In rodents and songbirds, brain injury also induces the transcription and translation of aromatase in reactive astrocytes around the site of damage. Interestingly, this induction is more rapid in female zebra finches relative to males. Induced aromatization is neuroprotective, as inhibition of aromatase and estrogen replacement, increases and decreases the extent of damage, respectively. Although the consequences of induced astrocytic aromatization are intensely studied, little is known about what factors induce aromatase. Inflammation is sufficient to induce astrocytic aromatase suggesting that the link between inflammation and aromatase expression may be causal. To test this hypothesis, adult male and female zebra finches received bilateral mechanical injuries through which either the cyclooxygenase (COX)-1/2 inhibitor indomethacin or vehicle was administered into contralateral hemispheres. Subjects were killed either 6 or 24 hours after injury. In both sexes, an enzyme immunoassay for prostaglandin E 2 (PGE 2 ) revealed that indomethacin decreased PGE 2 relative to the contralateral hemisphere at both time points, suggesting that the dose and mode of administration used were successful in affecting neuroinflammation locally. Indomethacin reduced aromatase expression and 17b-estradiol (E 2 ) content at 6 hours but not 24 hours following injury in females. However, in males, the inhibitory effect of indomethacin on aromatase and E 2 was apparent at 24 but not 6 hours after treatment. These data suggest that COX activity, perhaps via consequent prostaglandin secretion, may induce aromatase expression and central E 2 , an effect that is detectable in temporally distinct patterns between sexes. (Endocrinology 158: 2585(Endocrinology 158: -2592(Endocrinology 158: , 2017 T he steroid 17b-estradiol (E 2 ) has been long recognized for its role in reproduction but also has a profound influence on other endpoints including but not limited to neuroprotection and the modulation of the innate immune system (1-3). Many peripheral tissues synthesize E 2 , but this steroid is also synthesized in the brain via the expression of the enzyme aromatase at discrete loci. Indeed, brain-derived E 2 regulates adult neurogenesis, neuronal survival, neuronal death, and neuroinflammation (4-6). In mammals and birds, neural aromatase is normally restricted to neurons constitutively. However, aromatase expression is induced in reactive astrocytes following damage to the mammalian and avian neuropil including that of songbirds (7-14).
T he steroid 17b-estradiol (E 2 ) has been long recognized for its role in reproduction but also has a profound influence on other endpoints including but not limited to neuroprotection and the modulation of the innate immune system (1-3). Many peripheral tissues synthesize E 2 , but this steroid is also synthesized in the brain via the expression of the enzyme aromatase at discrete loci. Indeed, brain-derived E 2 regulates adult neurogenesis, neuronal survival, neuronal death, and neuroinflammation (4) (5) (6) . In mammals and birds, neural aromatase is normally restricted to neurons constitutively. However, aromatase expression is induced in reactive astrocytes following damage to the mammalian and avian neuropil including that of songbirds (7) (8) (9) (10) (11) (12) (13) (14) .
Glial aromatization of E 2 has been intensely studied over the past decade. In the zebra finch (Taeniopygia guttata) brain, glial aromatase is induced within hours and can last up to 6 weeks following mechanical injury (15, 16) . The consequent E 2 synthesis can increase local E 2 levels fourfold in an injured telencephalic hemisphere relative to the contralateral uninjured lobe (17) . Interestingly, mechanical injury results in a more rapid induction of astrocytic aromatase in females relative to males (15) . This glial aromatization and local increase in E 2 is neuroprotective. Mechanical brain damage in the presence of fadrozole or in aromatase-knockout mice reveals increases in the size of injury, the number of apoptotic cells (11) , reactive gliosis (16) , inflammation (18) , and neuronal damage, relative to vehicle-treated or wild-type controls (19, 20) . Replacement with E 2 reverses these effects and decreases the number of apoptotic cells (12) , the amount of neuronal damage (21) , and inflammatory signaling (18) with corresponding increases in neurogenesis (22, 23) . These data suggest that glial aromatase may regulate several aspects of neuronal turnover around the site of damage and may be a potent antiinflammatory agent. Although the consequences of glial aromatization are well studied, the mechanism responsible for the induction of aromatase remains unknown in any vertebrate.
Inflammatory processes themselves may play an inductive role in the expression of aromatase following penetrating brain injury. Cytokines, potent inducers of inflammatory signaling, regulate aromatase gene expression in normal and malignant breast tissue (24) (25) (26) (27) and may influence neural aromatase expression in a similar manner. In a previous study, we have shown that central application of the inflammagen phytohemagglutinin increases the cytokines interleukin-1b and interleukin-6 and aromatase expression in reactive astrocytes (28) . Thus, inflammatory signaling appears sufficient to induce glial aromatase in the finch brain. However, because phytohemagglutinin stimulates multiple components of the inflammatory pathway including the stimulation of macrophages, T cells, cytokines, and prostaglandin synthesis, the specific signal that induces glial aromatase remains unclear (28) (29) (30) .
In rats, administration of prostaglandin E 2 (PGE 2 ) during a restricted neonatal period induces E 2 synthesis via neuronal aromatization (31, 32) . PGE 2 is a proinflammatory signal and is induced following injury via the enzyme cyclooxygenase (COX)-2 (33) (34) (35) (36) . Administration of the COX-1/2 inhibitor indomethacin during development reduced cerebellar aromatase and E 2 and had dramatic effects on dendritic morphology and neurophysiology (37, 38) . Thus, local COX activity and consequent PGE 2 synthesis can regulate aromatase activity in the mammalian brain. However, little is known about PGE 2 's influence on aromatase in the adult brain, the injured brain, or in any nonrodent species.
Given the interactions between inflammatory signaling and E 2 induction in various models, we hypothesize that inflammatory signaling, specifically PGE 2 , induces aromatase and E 2 synthesis following penetrating brain injury. In the current study, we used zebra finches due to their reliable and robust induction of aromatase (15, 16) . We administered indomethacin, a COX-1/2 inhibitor or vehicle during injury and first measured PGE 2 to test the efficiency of the inhibition. We then measured aromatase and central E 2 to test whether indomethacin administration affected injury-induced aromatase and E 2 .
Methods
Subjects were thirty adult zebra finches (n = 15 per sex) housed at American University. Subjects were housed in same-sex cages in a temperature-controlled room (72°C 6 2°C) on a 12:12-hour light:dark cycle. Five animals of the same sex were housed in one cage until euthanasia. Food and water were provided ad libitum. The American University Institutional Animal Care and Use Committee approved all procedures.
Surgery
To test the effect of COX-1/2 activity on aromatase and E 2 induction, we used a within-subject design with the administration of indomethacin or vehicle into contralateral hemispheres. As previously reported (11, 18) , subjects were anesthetized with isoflurane and positioned in a stereotaxic apparatus. The cranium was exposed by midline incision, and a bilateral craniotomy was created. A 22-G needle was then inserted into the brain and held in place for 60 seconds. We targeted the entopallial nucleus due to its lack of constitutive aromatase (11, 16, 18) . Then, either 10 mL of a 15-mg/mL solution of indomethacin dissolved in 5% ethanol in 0.9% NaCl or 10 mL of vehicle was injected into each telencephalic hemisphere over 60 seconds and then left in place for 2 minutes after injection. The needle was retracted after injection, and the scalp was sealed with Collodion Flexible (EM Sciences, Hatfield, PA). Treatment and vehicle administration were counterbalanced to control for potential hemispheric differences. Following surgery, animals were euthanized either 6 or 24 hours after injury. These time points were chosen based on previous data from studies of the time course of aromatase induction (15, 16) , allowing us to target time points prior to (6 hours) and at the peak of (24 hours) aromatase induction following injury. Immediately following euthanasia, the telencephalon was dissected into four quadrants, as described previously (18) . Posterior quadrants (where the injury was located) were saved and stored at -80°until further processing, and the anterior brain was discarded.
A separate group of animals (n = 5 per sex) served as surgical and injury controls. Sham animal tissue was processed identically to that of experimental animals and included in every assay.
Tissue preparation
Prior to assays, posterior left or right hemispheres of injured animals were homogenized in 500 mL phosphate buffer. For shams, one of the posterior telencephalic samples counterbalanced to preclude hemispheric differences was homogenized in an identical volume of phosphate buffer. Samples were then divided into aliquots and used for three assays: an enzyme immunoassay (EIA) to measure PGE 2 , quantitative polymerase chain reaction (qPCR) to measure aromatase messenger RNA (mRNA), and an EIA to measure E 2 . Samples were stored at -80°C until day of assay.
Sample preparation and extraction for PGE 2 enzyme immunoassay
Samples were processed for ether and solid phase extractions according to previously published protocols (18, 39) . Briefly, 300 mL brain homogenate was combined with 3 mL diethyl ether and vortexed, centrifuged, and placed in a MeOH/dry ice bath. The organic phase was poured into a clean tube and dried down under air until fully evaporated. This was repeated for a total of three times. Then, 50 mL MeOH/CH 2 Cl 2 was added to tubes and was fully evaporated. Upon evaporation, samples were stored at -80°C until solid-phase extraction.
Ether extracted samples were reconstituted in 300 mL acetate buffer for solid phase extraction. C-18 cartridges were conditioned under vacuum pressure with ultrapure water and ethanol. Samples were applied to the cartridge and eluted into a waste bin and washed with ultrapure water. Then, 300 mL ethyl acetate was applied to the column and eluted into final collection tubes. Samples were then stored at -80°C until day of EIA.
PGE 2 enzyme immunoassay
On the day of the assay, samples were dried until evaporation and reconstituted with 300 mL EIA buffer and then further diluted 1:4. Samples were assayed in triplicates using a commercially available and validated PGE 2 EIA kit (Caymen Chemical, Ann Arbor, MI) (18) . Two spiked samples, processed in an identical manner and assayed in triplicates alongside the experimental samples to estimate recovery. Prior to ether and solid-phase extraction, an additional sample was spiked with PGE 2 to 125 pg/mL. For each time point, males and females were run at the same time to allow for the comparison of sex differences. The remaining reconstituted sample was placed at -80°C until the day of E 2 assay (see later).
Quantitative polymerase chain reaction
Homogenate (100 mL) was used to isolate total RNA using the RNeasy Mini Extraction Kit (Qiagen, Germantown, MD) according to the manufacturer's instruction, and purity of each extracted RNA sample was analyzed on an ND-1000 spectrophotometer (NanoDrop, Wilmington, DE); 260/280 ratios exceeded 1.95 for all samples, with an average ;2.0. One microgram total RNA from each sample was reverse-transcribed using a High Capacity Complementary DNA Reverse Transcription Kit (Life Technologies, Carlsbad, CA) using a thermal cycler. Five microliters of the resulting complementary DNA was used to perform reverse transcription qPCR for each reaction using SYBR Select Master Mix (Life Technologies), for a total reaction volume of 50 mL divided into 15-mL triplicates. Primers for aromatase were used and previously validated (18) . Samples were run on 96-well plates (Bio-Rad, Hercules, CA). All male or female samples for one time point were run on one plate to reduce variability. A no-template control and a no-reverse-transcription control were run on each plate to eliminate the possibility of contaminants.
E 2 enzyme immunoassay
The remaining reconstituted sample (200 mL) from the PGE 2 assay was used for the E 2 EIA (Caymen Chemical). Samples, stored at -80°C, were removed on the day of the assay and diluted 1:2 with EIA buffer. Samples were assayed in triplicate using a commercially available and validated E 2 EIA kit (17, (40) (41) (42) . Similar to the PGE 2 EIA, two samples were spiked with E 2 to the concentration of 256 pg/mL to estimate recovery and ran alongside experimental samples. For each time point, males and females were run at the same time.
Statistics
All three measures were analyzed with a two-way nested model analysis of variance (ANOVA) with sex and treatment as main variables. Treatment included sham animals and animals that underwent surgery (indomethacin or vehicle in contralateral hemispheres). Indomethacin/vehicle was coded as "within subject" and nested within the main variable of "treatment." The source of significant main effects was queried using Tukey-Kramer post hoc analysis and significant interactions were assessed with Fisher least significant difference pairwise comparisons. Time points (6 and 24 hours after surgery) were analyzed separately to avoid excessive and uninformative comparisons that could obfuscate subtle statistically significant differences. For the PGE 2 EIA, data obtained in picograms per milliliter were converted to picograms per milligram to account for brain weight. For the qPCR data, statistical analyses were conducted on the delta threshold cycle (DCt) number method of quantification (18) but the data are presented as fold-changes following conversion using the 2 -D(DCT) formula. As with the PGE 2 EIA, the E 2 EIA data were converted to picograms per milligram to account for brain weight, and statistical analyses were conducted on these numbers.
Results

PGE 2 EIA
Six hours after treatment
To test the effectiveness of indomethacin treatment in the reduction of PGE 2 , we assessed PGE 2 levels with a commercially available EIA. At 6 hours after treatment, a two-way ANOVA revealed a main effect of treatment (F 2, 24 = 12.5, P , 0.01) but not of sex (F 2, 24 = 1.16, P = 0.29) or a sex 3 treatment interaction (F 2, 24 = 0.78, P = 0.46). Overall, indomethacin decreases PGE 2 levels in both males and females. Specifically, in males, sham animals had the lowest levels of PGE 2 content compared with injured animals regardless of treatment. However, injured lobes treated with indomethacin had lower PGE 2 content relative to injured lobes treated with vehicle. In females, injured controls have increased levels of PGE 2 content. Indomethacin reduced PGE 2 levels to sham levels. Data, presented in picograms per milligram, are shown is Fig. 1(a) .
Twenty-four hours after treatment
Statistical analysis revealed a main effect of treatment (F 2, 24 = 13.4, P , 0.01), with no significant main effect of sex (F 1, 24 = 1.34, P = 0.26 or a sex 3 treatment (F 2, 24 = 1.65 P = 0.21). Overall, indomethacin decreased central PGE 2 levels. Similar to 6-hour data, sham animals had the lowest level of central PGE 2 levels. However, indomethacin decreased PGE 2 compared with control injuries. Data, presented in picograms per milligram, are shown in Fig. 1(b) .
Aromatase qPCR
Six hours after treatment
Aromatase transcription varied significantly across sex (F 1, 24 = 9.57, P , 0.01), treatment (F 2, 24 = 14.50, P , 0.01), and a sex 3 treatment interaction (F 2, 24 = 19.60, P , 0.01). Sham animals had the lowest levels of aromatase compared with injured animals, regardless of treatment. In males, both vehicle and indomethacin injured animals had increased aromatase levels due to injury, and there were no differences between these two groups. However, in females, only injured controls have increased aromatase mRNA. Treatment with indomethacin reduced injury-induced aromatase mRNA.
Twenty-four hours after treatment
Statistical analysis revealed a main effect of treatment (F 2, 24 = 8.56, P , 0.01), with no main effect of sex (F 1, 24 = 3.48, P = 0.07), or a sex 3 treatment interaction (F 2, 24 = 2.46, P = 0.10). As with 24-hour data, sham animals had the lowest levels of central aromatase mRNA. In males, injured controls have an induction of aromatase compared with shams. However, the induction of aromatase was not seen with indomethacin treatment. In females, both injured controls and indomethacin animals had an induction of aromatase at 24 hours. Means + standard error of the mean of DCt for qPCR data are presented in Table 1 , and data transformed into fold change are presented in Fig. 2 .
E 2 EIA
Six hours after treatment
A two-way ANOVA indicated main effects of sex (F 1, 24 = 6.56 P = 0.01), treatment (F 2, 24 = 15.70, P , 0.01), and their interaction (F 2, 24 = 8.72, P , 0.01). In males, E 2 content was not different between all three groups. Injured males, regardless of treatment, do not have different levels of E 2 compared with shams. However, in females, shams have the lowest levels of E 2 . At 6 hours, injured controls have an induction of E 2 . However, treatment with indomethacin decreases E 2 content compared with injured controls. Data presented in picograms per milligram are shown in Fig. 3(a) .
Twenty-four hours after treatment
At 24 hours after treatment, there was a main effect of treatment (F 2, 24 = 6.62, P , 0.01), with no main effect of sex (F 1, 24 = 0.48, P = 0.49) but a treatment 3 sex interaction (F 2, 24 = 3.22, P = 0.05). In males, injured controls have an induction of E 2 24 hours after treatment. However, treatment with indomethacin decreases E 2 levels in injured males. Interestingly, E 2 content in indomethacin males is not different from shams. In females, shams have the lowest levels of E 2 . Injured animals, regardless of treatment, have increased E 2 levels. Data presented in picograms per milligram are shown in Fig. 3(b) .
Discussion
Although the consequences of aromatase and E 2 following injury have been well documented, the mechanism(s) responsible for the injury-induced increase in neural aromatase has remained unclear. In the current study, Figure 1 . Levels of PGE 2 following bilateral injury with indomethacin administration or control in adult male and female zebra finches. At (a) 6 hours and (b) 24 hours, both male and female controls have increased PGE 2 following injury to the brain compared with shams. Treatment with indomethacin decreases PGE 2 levels in both sexes and at both time points. Groups that do not share a letter are significantly different (P , 0.05). The effect of indomethacin is depicted in italics, and statistically significant differences are depicted following a conversion to fold-change in Fig. 2 .
we tested if prostaglandin inhibition prevents the wellestablished upregulation of aromatase and E 2 following penetrating brain injury. First, we measured PGE 2 and found that hemispheres treated with indomethacin had decreased PGE 2 at both 6 and 24 hours following treatment. We then measured aromatase transcription and central levels of E 2 . We found that vehicle-treated lobe of injured animals had higher aromatase expression and E 2 content relative to shams, underscoring the reliable and robust injury-induced upregulation of aromatization in this species. Within the injured animals, indomethacin mitigated or completely prevented injuryinduced aromatase expression and E 2 content. This influence was observable sooner following injury in females relative to males. More specifically, at both time points and in both sexes, telencephalic lobes injured in the presence of vehicle have increased aromatase and E 2 levels compared with sham, which replicates and supports many years of injury-induced aromatase and E 2 data (7) (8) (9) (10) (11) (12) (13) (14) 17) . However, treatment with indomethacin inhibits the welldocumented increases in aromatase and E 2 . Females fail to increase aromatase and E 2 at 6 hours when treated with indomethacin, an effect not apparent 24 hours after surgery. Males, however, do have injury-induced increases in E 2 6 hours after injury, which supports previous research detailing that females induce aromatase faster than males, and as early as 2 hours (15). At 24 hours, there is no significant induction of aromatase and E 2 . It is important to note that indomethacin treatment appears to be effective at both time points in both sexes, given that the hemisphere treated with indomethacin has significantly decreased PGE 2 . Thus, although there is evidence suggesting a role for indomethacin (and, consequently, COX) in the induction of aromatase following injury, other factors may also be contributing to this effect. More specifically, injury-associated changes other than PGE 2 may be responsible for the induction and/or maintenance of upregulated E 2 synthesis in response to injury. Indeed cytokine administration increases aromatase expression in breast-cancer cells in vitro (24) (25) (26) , suggesting the possibility that inflammatory pathways independent of COX could influence aromatase expression in the brain. Future work in our laboratory will explore this effect. Previous work has suggested that prostaglandins regulate aromatase and E 2 expression neonatally (31, 37, 38) , and current data suggest that they also might do so in the injured zebra finch brain. Taken together, these data suggest that COX activity, perhaps via prostaglandin signaling, is necessary for injury-induced aromatase and E 2 .
We propose a feedback model between prostaglandin signaling and E 2 synthesis following brain injury, representing a novel relationship between immune and endocrine systems in the brain. Inflammatory signaling, particularly prostaglandin synthesis caused by brain injury, induces aromatase transcription, and this induction results in the sustained synthesis of E 2 at the site of damage (current study). This induction can serve as a neuroprotectant by decreasing neuroinflammation, including cytokines, COX-2, and PGE 2 (18) . Inflammatory signaling can have beneficial and detrimental effects following injury, which are likely due to the acute and chronic inflammatory signaling cascades. At first, inflammatory signaling helps contain the damage and maintain tissue integrity, thereby limiting damage. Prolonged or chronic inflammatory signaling, however, can promote toxic signaling cascades and further degeneration (43) (44) (45) (46) . Induced E 2 , via PGE 2 signaling, may serve to decrease inflammation (18), along with decreasing degeneration (16) and increasing repair (11, 23) . Current work in our laboratory is investigating which prostaglandin and estrogen receptors are necessary for the observed effects and how these receptors may be expressed relative to each other in the injured songbird brain.
Prostaglandins are known regulators of aromatase and, therefore, E 2 in breast cancer cells, the neonatal rat brain (37, 38, 47) and now, following brain injury, the songbird. However, the receptor(s) responsible for this action are unknown. There are four main prostanoid receptors that PGE 2 can bind to, PGE 2 receptor subtypes 1 to 4. These G-protein-coupled receptors regulate downstream signaling pathways via PKC or PKA (48) . Our hypothesis is that PGE 2 may regulate aromatase via similar receptor pathways, as has been demonstrated in adipose stromal cells previously (47) .
From a therapeutic perspective, it is important to discover the mechanism of aromatase and E 2 induction following trauma. E 2 exerts a neuroprotective effect on neurologic disorders characterized by chronic inflammation, such as Alzheimer's disease, Parkinson's disease, stroke, and traumatic brain injury (49) . Further, decreases in E 2 via natural or surgical menopause increase indices of inflammation, an effect that is reversed upon hormone replacement therapy or E 2 administration (50, 51). On the converse, E 2 induction following temporal lobe seizures results in increased seizure activity (52) . Detailing the signal that induces E 2 during these insults may prove to be vital in the development of treatments. Sex differences in response to brain injury have been reported after traumatic brain injury and stroke, and E 2 signaling may play an important role in protection but also in recovery after injury (53) (54) (55) . The sex differences in response to indomethacin treatment (current study) must also be considered when considering the development of therapies to regulate aromatase and E 2 activity. How E 2 is exerting this anti-inflammatory act is unclear. E 2 mediates its effects through three known receptors, ER-a, ER-b, and G-protein-coupled estrogen receptor. These receptors are localized in neurons, astrocytes, and microglia but also immune cells (56) . We predict that estrogen receptors are vital in the reduction of inflammatory signaling following brain injury in our model (18) . Our laboratory is currently exploring these hypotheses.
The current study examines effects of aromatase and E 2 following injury, and we believe these effects are due to glial aromatization. In the zebra finch, there is extensive documentation of aromatase colocalization with astrocytes following brain injury, and changes in aromatase transcription correlate well with changes in astrocytic aromatase expression (8, (10) (11) (12) 15) . Thus, we believe that the observed effects are due to glial synthesis of E 2 . However, because the current study relies on homogenates that do not exclude neuronal aromatase, we cannot unequivocally conclude that indomethacin reduced the induction of glial aromatase. Current studies in our laboratory are exploring whether indomethacin reduces the amount of glial aromatase-positive cells following indomethacin treatment.
In summary, prostaglandin synthesis following injury may be necessary for induction of aromatase and E 2 . This effect, measured in the current report as a response to indomethacin and likely due to an inhibition of COX activity, appears to manifest differently in terms of temporal pattern between the sexes. These findings are a novel interaction between immune and endocrine systems after injury to the brain.
